CONMED (CNMD)
(Delayed Data from NYSE)
$68.67 USD
+3.33 (5.10%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $68.71 +0.04 (0.06%) 4:46 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
CNMD 68.67 +3.33(5.10%)
Will CNMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CNMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CNMD
CONMED (CNMD) Q2 Earnings Beat, Sales Rise Y/Y, '24 View Cut
Here's What Key Metrics Tell Us About Conmed (CNMD) Q2 Earnings
CNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Conmed (CNMD) Q2 Earnings Beat Estimates
Conmed (CNMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Here's Why You Should Retain CONMED (CNMD) Stock for Now
Other News for CNMD
Peeling Back The Layers: Exploring Conmed Through Analyst Insights
Stifel Nicolaus Sticks to Their Buy Rating for Conmed (CNMD)
Analysts Conflicted on These Healthcare Names: Teladoc (TDOC), SAGE Therapeutics (SAGE) and Conmed (CNMD)
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Conmed (CNMD)
Conmed: Q2 Earnings Snapshot